INFUSYSTEM HOLDINGS, INC Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax
INFUSYSTEM HOLDINGS, INC (INFU) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax of $136.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-03-11.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax · last filed 2014-03-11
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2012-12-31 was $135.00K, a 365.52% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2012-09-30 was $0.00.
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2012-06-30 was $0.00.
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2012-03-31 was $1.00K.
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2012 was $136.00K.
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2011 was -$72.00K.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 12 month |
|---|---|---|---|---|
| 2012-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $135.00K derived: sum of 2 quarters · filed 2014-03-11 | $135.00K derived: sum of 3 quarters · filed 2014-03-11 | $136.00K 10-K · filed 2014-03-11 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $1.00K 10-Q · filed 2013-11-12 | $30.00K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $1.00K 10-Q · filed 2013-08-13 | $30.00K derived: sum of 3 quarters · filed 2013-08-13 | -$37.00K derived: sum of 4 quarters · filed 2013-08-13 |
| 2012-03-31 | $1.00K 10-Q · filed 2013-05-13 | $30.00K derived: sum of 2 quarters · filed 2013-05-13 | -$37.00K derived: sum of 3 quarters · filed 2013-05-13 | -$118.00K derived: sum of 4 quarters · filed 2013-05-13 |
| 2011-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$38.00K derived: sum of 2 quarters · filed 2013-03-28 | -$119.00K derived: sum of 3 quarters · filed 2013-03-28 | -$72.00K 10-K · filed 2013-03-28 |
| 2011-09-30 | -$67.00K 10-Q · filed 2012-11-14 | -$148.00K derived: sum of 2 quarters · filed 2012-11-14 | -$101.00K 10-Q · filed 2012-11-14 | |
| 2011-06-30 | -$81.00K 10-Q · filed 2012-08-08 | -$34.00K 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |